Tagrisso 80 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FL4J9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,325
Award facts
- Contract value 100% obligated
- $21,325.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $21,325.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) under contract number 4569867706. The award, announced on October 29, 2025, with an ultimate completion date of November 20, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's substantial prime IDC (SPE2DX) valued at $999,999,999.00 and extending through December 2026, which provides comprehensive global pharmaceutical support to the Defense Health Agency and other federal healthcare customers. The contract vehicle enables the company to supply an extensive range of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. Tagrisso, an oncology medication, aligns with the company's established portfolio of specialty pharmaceuticals delivered through DLA's medical supply chain to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB26FL4J9?
SPE2DB26FL4J9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FL4J9 worth?
The government has obligated $21,325 on SPE2DB26FL4J9.
Is contract SPE2DB26FL4J9 an order under another contract?
Yes. SPE2DB26FL4J9 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB26FL4J9 competed?
The extent of competition for SPE2DB26FL4J9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award